These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15449906

  • 1. [Anti-tumor immunity in adult T-cell leukemia].
    Kannagi M.
    Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
    [Abstract] [Full Text] [Related]

  • 2. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
    Kannagi M, Ohashi T, Harashima N, Hanabuchi S, Hasegawa A.
    Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
    [Abstract] [Full Text] [Related]

  • 3. Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response.
    Hasegawa A, Ohashi T, Hanabuchi S, Kato H, Takemura F, Masuda T, Kannagi M.
    J Virol; 2003 Mar; 77(5):2956-63. PubMed ID: 12584320
    [Abstract] [Full Text] [Related]

  • 4. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
    Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Iida S.
    Cancer Sci; 2018 Aug; 109(8):2383-2390. PubMed ID: 29845702
    [Abstract] [Full Text] [Related]

  • 5. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.
    Ishihara Y, Tanaka Y, Kobayashi S, Kawamura K, Nakasone H, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Harada N, Kusuda M, Kameda K, Ugai T, Wada H, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Uchimaru K, Kanda Y.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724766
    [Abstract] [Full Text] [Related]

  • 6. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
    Shimizu Y, Takamori A, Utsunomiya A, Kurimura M, Yamano Y, Hishizawa M, Hasegawa A, Kondo F, Kurihara K, Harashima N, Watanabe T, Okamura J, Masuda T, Kannagi M.
    Cancer Sci; 2009 Mar 01; 100(3):481-9. PubMed ID: 19154412
    [Abstract] [Full Text] [Related]

  • 7. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.
    Immunol Lett; 2014 Mar 01; 158(1-2):120-5. PubMed ID: 24389072
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
    Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J, Kannagi M.
    Cancer Res; 2004 Jan 01; 64(1):391-9. PubMed ID: 14729650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
    Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.
    J Clin Immunol; 2012 Dec 01; 32(6):1340-52. PubMed ID: 22763862
    [Abstract] [Full Text] [Related]

  • 15. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
    Kitazono T, Okazaki T, Araya N, Yamano Y, Yamada Y, Nakamura T, Tanaka Y, Inoue M, Ozaki S.
    Cell Immunol; 2011 Dec 01; 272(1):11-7. PubMed ID: 22030472
    [Abstract] [Full Text] [Related]

  • 16. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients.
    Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, Hamada H, Che XF, Fujiwara H, Matsushita K, Tokunaga M, Haraguchi K, Uozumi K, Suzuki S, Takezaki T, Sonoda S.
    J Immunol; 2006 Oct 15; 177(8):5718-26. PubMed ID: 17015761
    [Abstract] [Full Text] [Related]

  • 17. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
    Kannagi M, Hasegawa A, Nagano Y, Iino T, Okamura J, Suehiro Y.
    Cancer Sci; 2019 Mar 15; 110(3):849-857. PubMed ID: 30666755
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M, Ganbaatar U, Hasegawa A, Takatsuka N, Kondo N, Yoneda T, Katagiri K, Masuda T, Utsunomiya A, Kannagi M.
    Cancer Sci; 2021 Mar 15; 112(3):1161-1172. PubMed ID: 33410215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.